Stay updated on Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision: v3.6.5 indicates a software version update for the page. The study details and content appear unchanged.
    Difference
    0.1%
    Check dated 2026-08-09T08:53:50.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 in the page footer, indicating a small site revision rather than changes to study details.
    Difference
    0.1%
    Check dated 2026-07-25T17:59:02.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing Revision: v3.6.2, indicating a minor version update to the page rendering. No study data or details appear to have been modified.
    Difference
    0.1%
    Check dated 2026-07-04T13:19:41.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, signaling a newer version of the page. This change is a metadata update and does not indicate a substantive modification to the study details.
    Difference
    0.1%
    Check dated 2026-06-27T05:59:26.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate the study is not enrolling, and new sections such as How to Read a Study Record, Common Questions, and How to Join a Study were added to help users navigate the page. The Interventions header formatting was adjusted (Intervention/Treatment) and the revision label updated to v3.6.0, reflecting UI and version changes.
    Difference
    0.5%
    Check dated 2026-06-13T04:33:00.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Revision label changed from v3.5.4 to v3.5.5, indicating a minor update to the site’s backend or presentation. This update does not modify study data, text, or other user-facing content.
    Difference
    0.1%
    Check dated 2026-06-05T22:52:51.000Z thumbnail image

Stay in the know with updates to Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page.